| Zacks Company Profile for Bayer Aktiengesellschaft (BAYRY : OTC) |
|
|
| |
| • Company Description |
| Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Number of Employees: 92,815 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $13.31 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 1,631,633 shares |
| Shares Outstanding: 3,930.00 (millions) |
| Market Capitalization: $52,308.30 (millions) |
| Beta: 0.68 |
| 52 Week High: $14.85 |
| 52 Week Low: $5.30 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
4.97% |
4.88% |
| 12 Week |
51.94% |
50.42% |
| Year To Date |
23.01% |
22.37% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Werner Baumann - Chief executive officer and Chairman
Wolfgang Nickl - Finance
Hartmut Klusik - Human Resources; Technology
Kemal Malik - Innovation
Erica Mann - Management members
|
|
Peer Information
Bayer Aktiengesellschaft (AGN.)
Bayer Aktiengesellschaft (NVS)
Bayer Aktiengesellschaft (NVO)
Bayer Aktiengesellschaft (LLY)
Bayer Aktiengesellschaft (RHHBY)
Bayer Aktiengesellschaft (JNJ)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Large Cap Pharma
Sector: Medical
CUSIP: 072730302
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 03/04/26
|
|
Share - Related Items
Shares Outstanding: 3,930.00
Most Recent Split Date: 9.00 (4.00:1)
Beta: 0.68
Market Capitalization: $52,308.30 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.17% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.69 |
Indicated Annual Dividend: $0.02 |
| Current Fiscal Year EPS Consensus Estimate: $1.52 |
Payout Ratio: 0.02 |
| Number of Estimates in the Fiscal Year Consensus: 3.00 |
Change In Payout Ratio: -0.15 |
| Estmated Long-Term EPS Growth Rate: 1.84% |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 03/04/26 |
|
|
|
| |
